U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial

UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

www.globenewswire.co...ine-in-COVID-19.html